Education Loan Available at Low Rate of Interest    Convert Your Course Fee In Easy And Flexible EMI    
Placements@ : accenture accutest Apcer Apollo artemis Aurobindo bioserve Bioxcel Chiltern Clinirx Cognizant Dabur Excel fortis-healthworld FreseniusKabi global_healthcity iCare icon intas Jubilant Max-Neeman Max Merck MMS MSD Novartis panaceaBiotech rajiv Ranbaxy Reliance ResMed Strides Syntel tcs torrent
Inside Cliniminds

Our Pharmacovigilance Training
Pharmaceutical Industry in Brazil

Brazil is amongst the top 10 pharmaceutical markets in the world with a market share of 3%. Brazil is one of the most attractive markets in the world. In Latin America, it is the main market, ahead of Mexico (USD 5.4 billion) and Argentina (USD 5.4 billion).
The market is dominated by sales of new medicines and biologicals, which comprise more than 40 percent of the revenue. Generic drugs, in comparison, accounted for only 13 percent of it.
Brazil's Pharmaceutical Market Value Will Approach $48 Billion. The Brazilian pharmaceutical market will expand in value from $29.4 billion in 2014 to reach approximately $47.9 billion by 2020, representing a strong Compound Annual Growth Rate (CAGR) of 8.5%, according to research and consulting firm GlobalData.
In 2017, the national drug market was comprised of 241 pharmaceutical companies, which were regulated and priced at CMED, thus being authorized to market drugs. Of the 241 companies, 97 (40%) were MNCs and 144 (60%) are domestic companies.
The sustained growth of the Brazilian pharmaceutical market has been nurtured by many different factors, which notably include particularly rapid demographic and epidemiological transitions. The increasing elderly population will lead to rising lifestyle and chronic diseases, as well as country’s investment in healthcare will be key drivers of market growth.
According to Senior Experts the Brazilian pharma market will continue to prosper because of country’s economic policies and reforms. Brazil has emerged has global manufacturing hub for pharmaceutical and biotechnology companies. Brazil is also witnessing rapid growth in generic drug market.
For more information contact us at ,,
+91- 9810068241, +91- 9560102589
For more information, log on to our website :
Google Reviews
Placements during
COVID-19 Pandemic
Certificate of Accreditation
Dr. Sandeep Bhatia
Medical Director & Senior Partner – Healthcare & Life Sciences
Dr. Sandeep Bhatia is Medical Affairs & Clinical Development leader with 15 years of Pharmaceutical and clinical research experience. Dr.Sandeep Bhatia
Dr Sandeep has worked extensively in field of Oncology Medical Affairs and headed Medical Affairs department for Global Pharmaceutical companies. He was the Head of Oncology Medical Affairs for MSD India and also led Medical Affairs team for Roche, India. Apart from this he has gained significant experience by working in companies like Novartis , Sanofi & Mylan.Read More...
FOLLOW Linkedin
WhatsApp Chat Whatsapp